Promoting Effective Drug Development Programs: Opportunities and Priorities for FDA’s Office of New Drugs; Public Meeting

1 organizations filed 1 public comment on Promoting Effective Drug Development Programs: Opportunities and Priorities for FDA’s Office of New Drugs; Public Meeting, at the Food and Drug Administration. The comment window closed 2394d ago.

Commenters (1)

• Consumer Healthcare Products Associationtrade assoc.

  1 filing · confidence 97%